+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America Orthobiologics Market Outlook to 2033 - Orthobiologics, Cartilage Repair and Others

  • PDF Icon

    Report

  • 144 Pages
  • November 2024
  • Region: North America
  • GlobalData
  • ID: 6029558
The “North America Orthobiologics Market Outlook to 2033” is a comprehensive databook report, covering key market data on the North America Orthobiologics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Orthobiologics, Cartilage Repair and Others

The North America Orthobiologics Market report provides key information and data on:

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2023 company share and distribution share data for Orthobiologics Market.
  • Global corporate-level profiles of key companies operating within the North America Orthobiologics Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

North America Orthobiologics is segmented as follows:

  • Bone Grafts and Substitutes
  • Bone Growth Stimulators
  • Cartilage Repair
  • Soft Tissue Biologics
  • Viscosupplementation

Reasons to Buy

North America Orthobiologics Market report helps you to develop:

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Orthobiologics Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Orthobiologics Market, North America
3.1 Orthobiologics Market, North America, Revenue ($m), 2018-2033
3.2 Orthobiologics Market, North America, Revenue ($m), 2018-2033
3.3 Orthobiologics Market, North America, Volume (Units), 2018-2033
3.4 Orthobiologics Market, North America, Volume (Units), 2018-2033
3.5 Orthobiologics Market, North America, Company Share by Revenue ($m), 2023
4 Orthobiologics Market, Canada
4.1 Orthobiologics Market, Canada, Revenue ($m), 2018-2033
4.1.1 Bone Grafts and Substitutes Market, Canada, Revenue ($m), by Segment, 2018-2033
4.1.2 Bone Growth Stimulators Market, Canada, Revenue ($m), by Segment, 2018-2033
4.1.3 Cartilage Repair Market, Canada, Revenue ($m), by Segment, 2018-2033
4.1.4 Soft Tissue Biologics Market, Canada, Revenue ($m), by Segment, 2018-2033
4.1.5 Viscosupplementation Market, Canada, Revenue ($m), by Segment, 2018-2033
4.2 Orthobiologics Market, Canada, Volume (Units), 2018-2033
4.2.1 Bone Grafts and Substitutes Market, Canada, Volume (Units), by Segment, 2018-2033
4.2.2 Bone Growth Stimulators Market, Canada, Volume (Units), by Segment, 2018-2033
4.2.3 Cartilage Repair Market, Canada, Volume (Units), by Segment, 2018-2033
4.2.4 Soft Tissue Biologics Market, Canada, Volume (Units), by Segment, 2018-2033
4.2.5 Viscosupplementation Market, Canada, Volume (Units), by Segment, 2018-2033
4.3 Orthobiologics Market, Canada, Average Price ($) , 2018-2033
4.4 Orthobiologics Market, Canada, Distribution Share by Revenue ($m), 2023
4.5 Orthobiologics Market, Canada, Company Share by Revenue ($m), 2023
5 Orthobiologics Market, Mexico
5.1 Orthobiologics Market, Mexico, Revenue ($m), 2018-2033
5.1.1 Bone Grafts and Substitutes Market, Mexico, Revenue ($m), by Segment, 2018-2033
5.1.2 Bone Growth Stimulators Market, Mexico, Revenue ($m), by Segment, 2018-2033
5.1.3 Cartilage Repair Market, Mexico, Revenue ($m), by Segment, 2018-2033
5.1.4 Soft Tissue Biologics Market, Mexico, Revenue ($m), by Segment, 2018-2033
5.1.5 Viscosupplementation Market, Mexico, Revenue ($m), by Segment, 2018-2033
5.2 Orthobiologics Market, Mexico, Volume (Units), 2018-2033
5.2.1 Bone Grafts and Substitutes Market, Mexico, Volume (Units), by Segment, 2018-2033
5.2.2 Bone Growth Stimulators Market, Mexico, Volume (Units), by Segment, 2018-2033
5.2.3 Cartilage Repair Market, Mexico, Volume (Units), by Segment, 2018-2033
5.2.4 Soft Tissue Biologics Market, Mexico, Volume (Units), by Segment, 2018-2033
5.2.5 Viscosupplementation Market, Mexico, Volume (Units), by Segment, 2018-2033
5.3 Orthobiologics Market, Mexico, Average Price ($), 2018-2033
5.4 Orthobiologics Market, Mexico, Distribution Share by Revenue ($m), 2023
5.5 Orthobiologics Market, Mexico, Company Share by Revenue ($m), 2023
6 Orthobiologics Market, United States
6.1 Orthobiologics Market, United States, Revenue ($m), 2018-2033
6.1.1 Bone Grafts and Substitutes Market, United States, Revenue ($m), by Segment, 2018-2033
6.1.2 Bone Growth Stimulators Market, United States, Revenue ($m), by Segment, 2018-2033
6.1.3 Cartilage Repair Market, United States, Revenue ($m), by Segment, 2018-2033
6.1.4 Soft Tissue Biologics Market, United States, Revenue ($m), by Segment, 2018-2033
6.1.5 Viscosupplementation Market, United States, Revenue ($m), by Segment, 2018-2033
6.2 Orthobiologics Market, United States, Volume (Units), 2018-2033
6.2.1 Bone Grafts and Substitutes Market, United States, Volume (Units), by Segment, 2018-2033
6.2.2 Bone Growth Stimulators Market, United States, Volume (Units), by Segment, 2018-2033
6.2.3 Cartilage Repair Market, United States, Volume (Units), by Segment, 2018-2033
6.2.4 Soft Tissue Biologics Market, United States, Volume (Units), by Segment, 2018-2033
6.2.5 Viscosupplementation Market, United States, Volume (Units), by Segment, 2018-2033
6.3 Orthobiologics Market, United States, Average Price ($), 2018-2033
6.4 Orthobiologics Market, United States, Distribution Share by Revenue ($m), 2023
6.5 Orthobiologics Market, United States, Company Share by Revenue ($m), 2023
7 Overview of Key Companies in North America Orthobiologics Market
7.1 Medtronic Plc
7.1.1 Company Overview
7.2 Sanofi
7.2.1 Company Overview
7.3 Bioventus Inc
7.3.1 Company Overview
7.4 Orthofix Holdings Inc
7.4.1 Company Overview
7.5 Stryker Corp
7.5.1 Company Overview
7.6 Globus Medical Inc
7.6.1 Company Overview
7.7 AlloSource
7.7.1 Company Overview
7.8 LifeNet Health Inc
7.8.1 Company Overview
7.9 Zimmer Biomet Holdings Inc
7.9.1 Company Overview
7.10 ZimVie Inc
7.10.1 Company Overview
7.11 Surgalign Holdings Inc
7.11.1 Company Overview
8 Orthobiologics Market Pipeline Products
9 Recent Developments
9.1 Corporate Communications
9.1.1 Aug 21, 2024: AGFA HealthCare Announces the UK AGFA HealthCare User Group
9.1.2 Jul 05, 2024: Afamelanotide Assists DNA Repair Response Following UV Radiation
9.1.3 Mar 25, 2024: Stony Brook Professor George Leibowitz Assumes Role from Interim Dean Richard L. Edwards
9.1.4 Feb 05, 2024: Ultima Genomics to Launch UG 100 System and Present Data at AGBT
9.2 Financial Announcements
9.2.1 Sep 30, 2024: ChitogenX Announces Q2 2025 Results
9.2.2 Aug 07, 2024: Zimmer Biomet Announces Second Quarter 2024 Financial Results
9.2.3 Aug 01, 2024: Lineage Cell Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024
9.2.4 Jul 31, 2024: ATEC Reports Second Quarter 2024 Financial Results And Raises Full-Year Guidance
9.2.5 Jul 29, 2024: Ocugen to Host Conference Call on Thursday, August 8 at 8:30 A.M. ET to Discuss Business Updates and Second Quarter 2024 Financial Results
9.2.6 Jul 17, 2024: Baxter to Host Second-Quarter 2024 Financial Results Conference Call for Investors
9.2.7 Jul 15, 2024: Integra LifeSciences to Host Second Quarter 2024 Financial Results Conference Call on July 29, 2024
9.2.8 Jul 10, 2024: ATEC to Report Second Quarter Financial Results on July 31, 2024
9.2.9 Feb 27, 2024: Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024
9.2.10 Jan 04, 2024: Baxter to Host Fourth-Quarter 2023 Financial Results Conference Call for Investors
9.2.11 Oct 16, 2023: MIMEDX to Host Third Quarter 2023 Operating and Financial Results Conference Call on October 30
9.2.12 Oct 10, 2023: Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023
9.3 Government and Public Interest
9.3.1 Jul 22, 2024: Arcutis to Host Zoryve (Roflumilast) Cream 0.15% FDA Approval Call with KOL
9.3.2 Jun 01, 2024: Typhoid Fever Vaccine “Tyfim V-I Injection Syringe” Information Regarding Obtaining Manufacturing and Sales Approval
9.3.3 May 07, 2024: Baxter to Present at Bank of America 2024 Health Care Conference
9.3.4 Oct 10, 2023: Twenty Years of the Nuvasive XLIF Procedure Celebrated at the Society for Minimally Invasive Spine Surgery 2023 Annual Forum
9.4 Legal And Regulatory
9.4.1 May 14, 2024: Valcare Medical Announces Enrollment of First Two Patients in AMEND TS EU Pilot Study
9.4.2 Mar 24, 2024: Ultradent Products Receives 510(K) Clearance For FORMA Composite (Shade A3D)
9.4.3 Mar 13, 2024: Edwards presents positive data from two valve studies at CRT 2024
9.5 Other Significant Developments
9.5.1 Feb 12, 2024: Tyber Medical Acquires FDA Clearance for Proximal Tibia Plating System
9.5.2 Oct 11, 2023: SINTX Technologies Awarded Phase II NIH Grant for Silicon Nitride-PEEK 3D Printed Composite Spinal Implants
9.6 Product News
9.6.1 Oct 31, 2023: Affamed Therapeutics Announced Positive Top-Line Results of Dextenza Inafter Cataract Surgery
10 Appendix
10.1 Research Methodology
10.1.1 Coverage
10.1.2 Secondary Research
10.1.3 Primary Research
10.1.4 Market Modeling and Forecasting
10.1.5 Company Share Analysis
10.1.6 Distribution Share Analysis
10.1.7 Benchmarking
10.2 the analyst Consulting
10.3 Contact the Publisher
10.4 Disclaimer
List of Tables
Table 1: Orthobiologics Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033
Table 2: Orthobiologics Market, North America, Revenue ($m), USD Constant, 2018-2033
Table 3: Orthobiologics Market, North America, Volume (Units), 2018-2033
Table 4: Orthobiologics Market, North America, Volume (Units), 2018-2033
Table 5: Orthobiologics Market, North America, Company Share by Revenue ($m), USD Constant, 2023
Table 6: Orthobiologics Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 7: Bone Grafts and Substitutes Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 8: Bone Growth Stimulators Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 9: Cartilage Repair Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 10: Soft Tissue Biologics Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 11: Viscosupplementation Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 12: Orthobiologics Market, Canada, Volume (Units), 2018-2033
Table 13: Bone Grafts and Substitutes Market, Canada, Volume (Units), 2018-2033
Table 14: Bone Growth Stimulators Market, Canada, Volume (Units), 2018-2033
Table 15: Cartilage Repair Market, Canada, Volume (Units), 2018-2033
Table 16: Soft Tissue Biologics Market, Canada, Volume (Units), 2018-2033
Table 17: Viscosupplementation Market, Canada, Volume (Units), 2018-2033
Table 18: Orthobiologics Market, Canada, Average Price ($), 2018-2033
Table 19: Orthobiologics Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2023
Table 20: Orthobiologics Market, Canada, Company Share by Revenue ($m), USD Constant, 2023
Table 21: Orthobiologics Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Table 22: Bone Grafts and Substitutes Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Table 23: Bone Growth Stimulators Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Table 24: Cartilage Repair Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Table 25: Soft Tissue Biologics Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Table 26: Viscosupplementation Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Table 27: Orthobiologics Market, Mexico, Volume (Units), 2018-2033
Table 28: Bone Grafts and Substitutes Market, Mexico, Volume (Units), 2018-2033
Table 29: Bone Growth Stimulators Market, Mexico, Volume (Units), 2018-2033
Table 30: Cartilage Repair Market, Mexico, Volume (Units), 2018-2033
Table 31: Soft Tissue Biologics Market, Mexico, Volume (Units), 2018-2033
Table 32: Viscosupplementation Market, Mexico, Volume (Units), 2018-2033
Table 33: Orthobiologics Market, Mexico, Average Price ($), 2018-2033
Table 34: Orthobiologics Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2023
Table 35: Orthobiologics Market, Mexico, Company Share by Revenue ($m), USD Constant, 2023
Table 36: Orthobiologics Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 37: Bone Grafts and Substitutes Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 38: Bone Growth Stimulators Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 39: Cartilage Repair Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 40: Soft Tissue Biologics Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 41: Viscosupplementation Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 42: Orthobiologics Market, United States, Volume (Units), 2018-2033
Table 43: Bone Grafts and Substitutes Market, United States, Volume (Units), 2018-2033
Table 44: Bone Growth Stimulators Market, United States, Volume (Units), 2018-2033
Table 45: Cartilage Repair Market, United States, Volume (Units), 2018-2033
Table 46: Soft Tissue Biologics Market, United States, Volume (Units), 2018-2033
Table 47: Viscosupplementation Market, United States, Volume (Units), 2018-2033
Table 48: Orthobiologics Market, United States, Average Price ($), 2018-2033
Table 49: Orthobiologics Market, United States, Distribution Share by Revenue ($m), USD Constant, 2023
Table 50: Orthobiologics Market, United States, Company Share by Revenue ($m), USD Constant, 2023
Table 51: Orthobiologics Market Pipeline Products
Table 52: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country
List of Figures
Figure 1: Orthobiologics Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033
Figure 2: Orthobiologics Market, North America, Revenue ($m), USD Constant, 2018-2033
Figure 3: Orthobiologics Market, North America, Volume (Units), 2018-2033
Figure 4: Orthobiologics Market, North America, Volume (Units), 2018-2033
Figure 5: Orthobiologics Market, North America, Company Share (%) 2023
Figure 6: Orthobiologics Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 7: Bone Grafts and Substitutes Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 8: Bone Growth Stimulators Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 9: Cartilage Repair Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 10: Soft Tissue Biologics Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 11: Viscosupplementation Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 12: Orthobiologics Market, Canada, Volume (Units), 2018-2033
Figure 13: Bone Grafts and Substitutes Market, Canada, Volume (Units), 2018-2033
Figure 14: Bone Growth Stimulators Market, Canada, Volume (Units), 2018-2033
Figure 15: Cartilage Repair Market, Canada, Volume (Units), 2018-2033
Figure 16: Soft Tissue Biologics Market, Canada, Volume (Units), 2018-2033
Figure 17: Viscosupplementation Market, Canada, Volume (Units), 2018-2033
Figure 18: Orthobiologics Market, Canada, Company Share (%) 2023
Figure 19: Orthobiologics Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Figure 20: Bone Grafts and Substitutes Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Figure 21: Bone Growth Stimulators Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Figure 22: Cartilage Repair Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Figure 23: Soft Tissue Biologics Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Figure 24: Viscosupplementation Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Figure 25: Orthobiologics Market, Mexico, Volume (Units), 2018-2033
Figure 26: Bone Grafts and Substitutes Market, Mexico, Volume (Units), 2018-2033
Figure 27: Bone Growth Stimulators Market, Mexico, Volume (Units), 2018-2033
Figure 28: Cartilage Repair Market, Mexico, Volume (Units), 2018-2033
Figure 29: Soft Tissue Biologics Market, Mexico, Volume (Units), 2018-2033
Figure 30: Viscosupplementation Market, Mexico, Volume (Units), 2018-2033
Figure 31: Orthobiologics Market, Mexico, Company Share (%) 2023
Figure 32: Orthobiologics Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 33: Bone Grafts and Substitutes Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 34: Bone Growth Stimulators Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 35: Cartilage Repair Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 36: Soft Tissue Biologics Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 37: Viscosupplementation Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 38: Orthobiologics Market, United States, Volume (Units), 2018-2033
Figure 39: Bone Grafts and Substitutes Market, United States, Volume (Units), 2018-2033
Figure 40: Bone Growth Stimulators Market, United States, Volume (Units), 2018-2033
Figure 41: Cartilage Repair Market, United States, Volume (Units), 2018-2033
Figure 42: Soft Tissue Biologics Market, United States, Volume (Units), 2018-2033
Figure 43: Viscosupplementation Market, United States, Volume (Units), 2018-2033
Figure 44: Orthobiologics Market, United States, Company Share (%) 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Sanofi
  • Medtronic Plc
  • Stryker Corp